The following notes are relevant:

i$)$ Non$-$current assets:

On $1$ April $2022$ the directors of Atlas Co decided that the financial statements

would show an improved position if the land and buildings were revalued to market

value. At that date an independent valuer valued the land at $12$ million and the

buildings at $35$ million and these valuations were accepted by the directors. The

remaining life of the buildings at that date was $14$ years. Atlas Co does not make

a transfer to retained earnings for excess depreciation. Ignore deferred tax on the

revaluation surplus.

Plant and equipment is depreciated at $20\%$ per annum using the reducing balance

method and time apportioned as appropriate. All depreciation is charged to cost of

sales, but none has yet been charged on any non$-$current asset for the year ended

$31$ March $2023.$

ii$)$ Atlas Co estimates that an income tax provision of $27\mathrm{.}2$ million is required for the

year ended $31$ March $20$X$3$ and at that date the liability to deferred tax is $9\mathrm{.}4$

million. The movement on deferred tax should be taken to profit or loss. The

balance on current tax in the trial balance represents the under$/$over provision of

the tax liability for the year ended $31$ March $2022.$

Required

a$)$ Prepare the statement of profit or loss and other comprehensive income for Atlas Co

for the year ended $31$ March $2023.$

The following trial balance relates to Atlas Co as $31$ March $2023.$

$($b$)$ Prepare the statement of financial position of Atlas Co as at $31$ March $2023.$

$($c$)$ Calculate basic earnings per share for the year ended $31$ March $2023.$